Page last updated: 2024-08-24

mivazerol and Coronary Disease

mivazerol has been researched along with Coronary Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Lange, S; Prinzen, FW; Roekaerts, PM; Willigers, HM1
Goldman, L; Holme, I; Julian, DG; Oliver, MF1

Trials

1 trial(s) available for mivazerol and Coronary Disease

ArticleYear
Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT).
    Anesthesiology, 1999, Volume: 91, Issue:4

    Topics: Adrenergic alpha-Agonists; Aged; Anesthesia, General; Coronary Disease; Double-Blind Method; Female; Humans; Imidazoles; Intraoperative Complications; Male; Placebos; Postoperative Complications; Risk Factors; Surgical Procedures, Operative; Sympatholytics; Vascular Surgical Procedures

1999

Other Studies

1 other study(ies) available for mivazerol and Coronary Disease

ArticleYear
The effects of alpha 2-adrenergic stimulation with mivazerol on myocardial blood flow and function during coronary artery stenosis in anesthetized dogs.
    Anesthesia and analgesia, 1996, Volume: 82, Issue:4

    Topics: Adrenergic alpha-Agonists; Animals; Cardiac Output; Catecholamines; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Imidazoles; Myocardial Contraction; Myocardium; Oxygen Consumption; Regional Blood Flow; Vascular Resistance

1996